Target intelligence / Profile preview

Fungal cellular structures

Molecular classification
Other
01

Overview

Fungal cellular structures encompass the unique physical and biochemical components of fungal cells, such as the cell wall and cell membrane, which are essential for maintaining structural integrity and osmotic stability [1]. The fungal cell wall is primarily composed of chitin, glucans, and mannoproteins, while the cell membrane contains ergosterol, a sterol absent in mammalian cells [2]. These structures serve as the primary targets for most antifungal classes; for example, echinocandins inhibit (1,3)-beta-D-glucan synthase in the cell wall, and azoles inhibit the synthesis of ergosterol [3]. Because these targets are specific to fungi, they allow for selective toxicity, though the broad nature of this category includes various distinct molecular targets [1][4]. Disruption of these structures leads to cell lysis or growth inhibition, making them critical for treating systemic and superficial fungal infections [2][5]. Beyond structural roles, these components are involved in signal transduction, nutrient uptake, and evasion of the host immune system [2]. Therapeutic challenges include the development of resistance and the potential for cross-reactivity or toxicity in the host, particularly with drugs targeting the cell membrane [1][4].

Other names
Fungal cell componentsFungal cell wallFungal cell membraneFungal organelles
02

Mechanism of action

Antifungal agents target fungal cellular structures through various mechanisms: polyenes bind to ergosterol to create pores in the cell membrane; azoles and allylamines inhibit enzymes in the ergosterol biosynthetic pathway; echinocandins inhibit (1,3)-beta-D-glucan synthase to disrupt cell wall synthesis; and antimetabolites like flucytosine interfere with nucleic acid synthesis.

03

Biological functions

Structural integrityOsmotic protectionSelective permeabilityCellular metabolismImmune evasion
04

Disease associations

InfectionMycosisCandidiasisAspergillosis
05

Safety considerations

NephrotoxicityHepatotoxicityDrug-drug interactions via Cytochrome P450 inhibitionInfusion-related reactionsElectrolyte imbalances
06

Interacting drugs

Amphotericin B

9 more in the full profile.

07

Biomarkers

(1,3)-beta-D-glucanGalactomannanCryptococcal antigen

Beyond the preview

Go deeper on Fungal cellular structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal cellular structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call